Predicting the restenosis benefit of drug-eluting versus bare metal stents in percutaneous coronary intervention

Field Value
Model ID11-035-02
Model NameYeh 2011 - Including Angiographic Characteristics
Pubmed ID21900079
First AuthorYeh
JournalCirculation
Year2011
TitlePredicting the restenosis benefit of drug-eluting versus bare metal stents in percutaneous coronary intervention
Primary Index ConditionCoronary Artery Disease (CAD)
Secondary Index ConditionRevascularization
OutcomeRevascularization
Model Sample Size18071
Cohort Sample Size27107
Number of Events2047
Follow-Up DurationLong (>6 months)
AUROC0.66
Calibration Reported1
CovariatesIntercept; Drug-eluting stent; Age <=50; Age 50-80; Age >=80; Diabetes; Peripheral vascular disease; Hypertension; Previous PCI: none; Previous PCI: <=1 year; Previous PCI: >1 year or timing unknown; NYHA class I; NYHA class II; NYHA class III; NYHA class IV; Admissions symptoms: none; Admissions symptoms: atypical chest pain; Admissions symptoms: stable angina; Admissions symptoms: unstable angina; Admissions symptoms: non-STEMI; Admissions symptoms: STEMI; PCI indication: elective; PCI indication: urgent; PCI indication: emergency or salvage; >=2 vessels with >=70% stenosis; Number of lesions treated; Stent diameter >=3.0 mm; Total stent length >=30 mm
Mesh TermsTo be updated
Number of Validations0

External Validations